| Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans S Azadnajafabad, E Mohammadi, A Aminorroaya, N Fattahi, S Rezaei, ... Journal of Diabetes & Metabolic Disorders, 1-9, 2021 | 116 | 2021 |
| Treatment of COVID‐19 with pentoxifylline: could it be a potential adjuvant therapy? F Seirafianpour, S Mozafarpoor, N Fattahi, A Sadeghzadeh‐Bazargan, ... Dermatologic therapy 33 (4), e13733, 2020 | 76 | 2020 |
| A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic … E Mohammadi, E Ghasemi, S Azadnajafabad, N Rezaei, ... PloS one 16 (2), e0247120, 2021 | 63 | 2021 |
| Epidemiologic pattern of cancers in Iran; current knowledge and future perspective E Mohammadi, A Aminorroaya, N Fattahi, S Azadnajafabad, N Rezaei, ... Journal of Diabetes & Metabolic Disorders 20 (1), 825-829, 2021 | 60 | 2021 |
| Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review M Mohamadi, A Goodarzi, A Aryannejad, N Fattahi, M Alizadeh-Khoei, ... Medical journal of the Islamic Republic of Iran 34, 123, 2020 | 52 | 2020 |
| Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017 S Azadnajafabad, S Saeedi Moghaddam, E Mohammadi, N Rezaei, ... Cancer medicine 10 (7), 2496-2508, 2021 | 51 | 2021 |
| Burden of non-communicable diseases in Iran: past, present, and future A Aminorroaya, N Fattahi, S Azadnajafabad, E Mohammadi, K Jamshidi, ... Journal of Diabetes & Metabolic Disorders, 1-7, 2020 | 50 | 2020 |
| Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019 M Abbasi-Kangevari, N Ahmadi, N Fattahi, N Rezaei, MR Malekpour, ... PloS one 17 (8), e0271284, 2022 | 33 | 2022 |
| Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017 A Aminorroaya, M Yoosefi, N Rezaei, M Shabani, E Mohammadi, ... European journal of preventive cardiology 29 (2), 371-379, 2022 | 30 | 2022 |
| A comprehensive review on COVID-19 infection and comorbidities of various organs NF Mohamadi M, Fattahi N, Goodarzi A, Alizadek-Khoei M, Miri Sh, Hekmat H ... Acta Medica Iranica, 4-14, 2021 | 28 | 2021 |
| Geographical, gender and age inequalities in non-communicable diseases both at national and provincial levels in Iran N Fattahi, S Azadnajafabad, E Mohammadi, A Aminorroaya, S Rezaei, ... Journal of Diabetes & Metabolic Disorders, 1-7, 2021 | 25 | 2021 |
| Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990–2017 A Aryannejad, M Tabary, N Ebrahimi, E Mohammadi, N Fattahi, ... Pancreatology 21 (8), 1443-1450, 2021 | 24 | 2021 |
| A report on statistics of an online self-screening platform for COVID-19 and its effectiveness in Iran S Azadnajafabad, SS Moghaddam, N Rezaei, E Ghasemi, ... International Journal of Health Policy and Management 11 (7), 1069, 2022 | 19 | 2022 |
| Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis B Khalilian, S Madadi, N Fattahi, B Abouhamzeh Journal of Molecular Histology 52, 125-134, 2021 | 19 | 2021 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... Lancet Gastroenterology & Hepatology 7 (7), 627-647, 2022 | 18 | 2022 |
| Protocol design for surveillance of risk factors of non–communicable diseases during the COVID-19 pandemic: an experience from Iran STEPS Survey 2021 S Djalalinia, S Azadnajafabad, E Ghasemi, M Yoosefi, N Rezaei, Y Farzi, ... Archives of Iranian medicine 25 (9), 634-646, 2022 | 16 | 2022 |
| Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients RN Kalmarzi, N Fattahi, Z Kaviani, P Ataee, M Mansouri, G Moradi, ... Allergology International 66 (2), 326-331, 2017 | 16 | 2017 |
| Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction … E Mohammadi, FS Morasa, S Roshani, N Rezaei, S Azadnajafabad, ... Journal of Diabetes & Metabolic Disorders 19, 1423-1430, 2020 | 12 | 2020 |
| Diarrhea as a presenting symptom of coronavirus disease 2019 in children B Moradveisi, P Ataee, A Ghaffarieh, A Karimi, N Fattahi, K Nasseri Advanced Biomedical Research 9 (1), 35, 2020 | 12 | 2020 |
| Physical activity pattern in Iran: Findings from STEPS 2021 SA Nejadghaderi, N Ahmadi, MM Rashidi, A Ghanbari, M Noori, ... Frontiers in Public Health 10, 1036219, 2023 | 10 | 2023 |
Farshad FarzadfarNon-Communicable Diseases Research Center ,Tehran University of Medical Sciences,Tehran,IRANVerified email at tums.ac.ir
